AVAH · NASDAQ · Medical - Care Facilities

Aveanna Healthcare (AVAH)

Provides home nursing, hospice, and medical-supply services across the United States.

$13.20
vs last close−0.24 (−1.79%)
Loading prices…

Aveanna Healthcare Holdings Inc.AVAH
Health Care

Provides home-based care through private duty services, home health and hospice, and medical solutions. Revenue is concentrated in private duty services, with reimbursement tied mainly to Medicaid, Medicare, managed-care organizations, and private payors.

Provides pediatric and adult care in the home through three reportable segments: Private Duty Services, Home Health & Hospice, and Medical Solutions. Services include skilled nursing, personal care, therapy, school nursing, hospice, and enteral-nutrition supply.

Operations are concentrated in the United States, with locations in 38 states. The platform was built from the 2017 combination of Epic Health Services and Pediatric Services of America, then expanded through acquisitions including Comfort Care and Thrive Skilled Pediatric Care.

Private Duty Services accounts for most revenue and is primarily reimbursed by Medicaid and Medicaid managed-care organizations. Home Health & Hospice is primarily reimbursed by Medicare, and the business depends on caregivers, referral sources, payor contracts, licensure, audits, and state-by-state service execution.

Company facts

CEOJeffrey S. Shaner
ListedApr 29, 2021
ExchangeNASDAQ
HeadquartersAtlanta, GA
CountryUnited States
Employees32,000
CIK0001832332
ISINUS05356F1057

Market cap$2.93B
EPS (ttm)$1.26
P/E (ttm)10.64
ROE150.2%
P/B10.19
P/S1.12
Dividend yieldDiv yield
Beta0.74vs XLV 0.49

Price target$15.00+11.6%Average of 12 analysts
ConsensusBuy7 of 12 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 28, 2026BarclaysReiterate
Rating: Target: $9.50
Rating: OverweightTarget: $15
Aug 24, 2026Truist FinancialTarget
Target: $11
Target: $15
Aug 21, 2026RBC CapitalReiterate
Rating: Target: $11
Rating: OutperformTarget: $16
Aug 14, 2026Deutsche BankReiterate
Rating: Target:
Rating: BuyTarget: $16
Aug 14, 2026UBSReiterate
Rating: Target: $10
Rating: NeutralTarget: $13

Next report
Nov 5, 26
in 44 days
EPS estimate
$0.20
Revenue estimate
$679.5M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.05$0.10$0.18$0.15$0.17$0.18$0.22Pending
Estimate$0.00$0.03$0.04$0.08$0.15$0.13$0.17$0.20
Surprise+216.8%+350.0%+87.5%+10.5%+38.5%+30.7%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$519.9M$559.2M$589.6M$621.9M$662.5M$647.9M$670.5MPending
Estimate$516.2M$527.3M$540.2M$649.5M$643.0M$613.2M$638.6M$679.5M
Surprise+0.7%+6.1%+9.1%−4.2%+3.0%+5.7%+5.0%
Estimate$0.20
ReportedDue Nov 5, 2026
Estimate$679.5M
ReportedDue Nov 5, 2026
View details

Debt to equity524.00%
Current ratio116.20%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$509.0M$519.9M$559.2M$589.6M$621.9M$662.5M$647.9M$670.5M
Net income−$42.8M$29.2M$5.2M$27.0M$14.1M$178.8M$41.7M$40.3M
Net margin0.0%5.6%0.9%4.6%2.3%27.0%6.4%6.0%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$34.0M$45.8M$51.8M$80.0M$56.3M$77.3M$75.9M$80.0M
YoY growthTurned profit+56.3%+126.5%+115.6%+65.4%+68.8%+46.6%−0.1%

Balance sheet, Jul 4, 2026Cash & short-term investments $97.2M · Total debt $1.51B · Total assets $2.11B · Shareholders' equity $287.3M

Revenue
$670.5M
Operating income
$80.0M
Net income
$40.3M
View details

No dividends on record.

Institutions≈ 92.36%201.54M shares
222 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail
Insiders2.53%5.52M shares
10 holders · as of Aug 24, 2026
Strategic holders7.11%15.52M shares
1 holder · as of Feb 10, 2026
Adds to102.00%

218.22M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

These groups come from separate filings that can overlap, so they add to 102.00%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Bain Capital Investors LLCInstitution
37.39%81.60Mas of Jun 30, 2026
BCPE Eagle Investor, LPInstitution
37.39%81.60Mfiled Feb 14, 2022
J.H. Whitney Equity Partners VII, LLCInstitution
12.40%27.06Mas of Jun 30, 2026
PSA Healthcare Investment Holdings LLCStrategic
7.11%15.52Mfiled Feb 10, 2026
Nut Tree Capital Management, LPInstitution
5.92%12.92Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Aug 21, 2026Robert M. Jr Williams10 percent owner−2,250,000$11.50
Aug 20, 2026Robert M. Jr Williams10 percent owner−1,148,048$11.50
Aug 21, 2026J.H. Whitney Equity Partners VII, LLC10 percent owner−2,250,000$11.50
Aug 20, 2026J.H. Whitney Equity Partners VII, LLC10 percent owner−2,383,952$11.50
Aug 21, 2026Paul R. Vigano10 percent owner−2,250,000$11.50
View details

Compare

CompanyPriceChange
Aveanna Healthcare$13.20−1.79%$2.93B10.615.41.1+13.7%
Addus HomeCare$116.33+0.84%$2.15B20.216.21.5+8.0%
BrightSpring Health Services$56.24+0.68%$10.96B41.727.60.8+23.0%
The Pennant Group$39.56+1.54%$1.35B43.327.21.2+35.8%
Chemed$500.14+0.10%$6.53B25.119.52.5+8.8%
Option Care Health$24.24+1.22%$3.59B18.012.40.6+1.9%
AdaptHealth$5.86+1.87%$782.3M0.3−7.5%
Median25.119.51.0+8.4%